中国化学快报(英文版)2024,Vol.35Issue(11) :74-86.DOI:10.1016/j.cclet.2024.109584

A natural nano-platform:Advances in drug delivery system with recombinant high-density lipoprotein

Zhilong Xie Guohui Zhang Ya Meng Yefei Tong Jian Deng Honghui Li Qingqing Ma Shisong Han Wenjun Ni
中国化学快报(英文版)2024,Vol.35Issue(11) :74-86.DOI:10.1016/j.cclet.2024.109584

A natural nano-platform:Advances in drug delivery system with recombinant high-density lipoprotein

Zhilong Xie 1Guohui Zhang 2Ya Meng 2Yefei Tong 1Jian Deng 1Honghui Li 3Qingqing Ma 4Shisong Han 2Wenjun Ni1
扫码查看

作者信息

  • 1. Zhuhai Clinical Medical College of Jinan University(The Department of Urology,Zhuhai People's Hospital),Zhuhai 519050,China
  • 2. Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment,Zhuhai Institute of Translational Medicine,Zhuhai People's Hospital(Zhuhai Clinical Medical College of Jinan University),Zhuhai 519050,China
  • 3. The Second Clinical Medical College,Guangdong Medical University,Dongguan 523808,China
  • 4. Guizhou Aerospace Hospital,Guizhou 563099,China
  • 折叠

Abstract

Developing natural nano-platforms with high biocompatibility and natural targeting ability represents great significance for drug delivery.High-density lipoprotein(HDL),a natural lipid-protein complex,plays important roles in physiological activities,particularly in reverse cholesterol transport(RCT)and be closely associated with atherosclerotic cardiovascular diseases.Recent studies have demonstrated that HDLs have the potential to serve as ideal drug carriers.Recombinant HDLs(rHDLs)have been used to en-capsulate substances such as small interfering RNA(siRNA),drugs,and contrast agents,fully utilizing the biocompatibility and targeting ability of rHDL in the body and providing new strategies for drug delivery and disease treatment.In this review,we discussed in detail the basic principles of HDL as a drug delivery system,the mechanisms of targeted drug delivery,and several methods for preparing HDL nanoparticles.Afterward,we comprehensively reviewed the applications of HDL as a drug carrier in cardiovascular dis-eases,cancer treatment(such as glioblastoma,breast cancer,hepatocellular carcinoma and urologic can-cers)and some other fields.Finally,we reviewed the therapeutic effects and safety of HDL nanoparticles in clinical studies.Through a review and summary of these research advances,we aim to fully understand the potential of HDL as a drug carrier in clinical applications,providing valuable references and guidance for future research and expedites the translational application of HDL as drug carriers.

Key words

High-density lipoproteins/Drug delivery/Apolipoprotein/Targeting mechanisms/HDL nanoparticle preparation/Cardiovascular disease/Cancer treatment

引用本文复制引用

出版年

2024
中国化学快报(英文版)
中国化学会

中国化学快报(英文版)

CSTPCDCSCD
影响因子:0.771
ISSN:1001-8417
段落导航相关论文